The Ovarian Cancer Research And Information Amendments Of 2001

Mr. Speaker, I rise today to announce that I am today introducing the Ovarian Cancer and Research Amendments of 2001. I am proud to be joined by 56 original co-sponsors and would like to invite the rest of my colleagues to join me in support of the bill.
Ovarian cancer is the most lethal cancer of the female reproductive system, primarily because it is so difficult to detect in its early stages. While survival rates are quite high if the disease is found before it spread beyond the ovaries, the five-year survival rate drops to 28% for women who are diagnosed and treated in the later stages of the disease. Only 25% of ovarian cancer cases are caught in the earliest stages.
The Ovarian Cancer and Research Amendments of 2001 have three components. First, it authorizes $150 million for ovarian cancer research: one- half to be spent on basic cancer research and one-half on clinical trials and treatment. The bill requires that priority be given to developing a test for the early detection of ovarian cancer; research to identify precursor lesions and to determine the manner in which benign conditions progress to malignant status; and research to determine the relationship between ovarian cancer and endometriosis. Moreover, the bill requires that appropriate counseling be provided to women participating in clinical trials.   Second, the bill provides for a comprehensive education program to provide information to patients and the public on screening procedures, the genetic basis to ovarian cancer, factors that increase the risk of getting ovarian cancer; and any new treatments for ovarian cancer.   Finally, it requires that the National Cancer Advisory Board include at least one individual who is at high risk of developing ovarian cancer.  I hope all my colleagues will join me in supporting this worthy cause and help to give women a fighting chance against ovarian cancer.

What is the price of Imatinib in India

Eating Lots Of Carbs May Raise Breast Cancer Risk, Study Finds

High-carb diets may increase more than just waistlines. New research suggests they might raise the risk of breast cancer. Women in Mexico who ate a lot of carbohydrates were more than twice as likely to get breast cancer than those who ate less starch and sugar, scientists found. The study is hardly the last word on the subject, but it is one of the few to examine how the popular but controversial low-carb diet craze might affect the odds of getting cancer, as opposed to its effects on cholesterol and heart disease. The new findings also don’t mean that it is safe or healthful to eat lots of meat, cheese or fats, as many people who go on low-carb diets do, experts say.
“There are many concerns with eating diets high in animal fat,” said Dr. Walter Willett, chief of nutrition at the Harvard School of Public Health. “If people do want to cut back on carbohydrates, it’s really important to do it in a way that emphasizes healthy fats, like salads with salad dressings.” Willett worked on the study with doctors at Instituto Nacional de Salud Publica in Cuernavaca, Mexico. It was funded by the U.S. Centers for Disease Control and Prevention, the Ministry of Health of Mexico, and the American
Institute for Cancer Research. Results were published Friday in the journal Cancer Epidemiology, Biomarkers & Prevention.
Fats, fiber and specific foods have long been studied for their effects on various types of cancer, but few firm links have emerged. Being overweight is known to raise risk, but the new study took that into account and still found greater risk from high carbohydrate consumption. Scientists think carbs may increase cancer risk by rapidly raising sugar in the blood, which prompts a surge of insulin to be secreted. This causes cells to divide and leads to higher levels of estrogen in the blood, both of which can encourage cancer.
A study earlier this year suggested that high-carb diets modestly raised the risk of colon cancer. Little research has been done on their effect on breast cancer, and results have been mixed. One study last year found greater risk among young women who ate a lot of sweets, especially sodas and desserts. For this study, researchers enrolled 475 women newly diagnosed with breast cancer and a comparison group of 1,391 healthy women in Mexico City who were matched for age, weight, childbirth trends and other factors that affect the odds of getting the disease.
Women filled out a lengthy food questionnaire developed by Willett and widely used in nutrition studies, and were divided into four categories based on how much of their total calories came from carbohydrates. Those in the top category — who got 62 percent or more of their calories from carbs — were 2.22 times more likely to have breast cancer than those in the lowest category, whose carb intake was 52 percent or less of their diet.
“The findings do raise concern about the possible adverse effects of eating lots of carbohydrates,” especially for people who have diabetes, insulin resistance or are overweight, Willett said. “It adds to the information that diet’s important” with respect to cancer risk, said John Milner, the National Cancer Institute’s chief of nutrition. How applicable the results are to American women is debatable. arbohydrates make up half of the typical American diet — less than what most of the women in this study consumed.
“The main carbohydrates these women ate were corn-derived, including tortillas, and soft drinks and bread,” said Dr. Eduardo Lazcano-Ponce, one of the Mexican physicians who did the study. Corn isn’t fortified with folate and other nutrients as are many grains, cereals and other sources of carbohydrates eaten in the United States, and those nutrients might help prevent cancer, noted Sandra Schlicker, executive director of the American Society for Clinical Nutrition.
Breast cancer rates in the United States are among the highest in the world. Nearly 132 cases are diagnosed for every 100,000 women. In Mexico, incidence is rising and is currently estimated at 38 cases per 100,000 women. But Willett cautioned that those rates are not adjusted for age differences and that the U.S. population is considerably older than Mexico’s and therefore more at risk of cancer.
In the study, women who ate a lot of insoluble fiber — found in whole grains, fruits and vegetables — had somewhat less risk of breast cancer. Fiber can modulate the absorption of carbohydrates. “It leads me to believe that healthier carb sources, or at least diets containing fiber, would be less strongly associated with breast cancer,” said Marji McCullough, a senior epidemiologist and nutrition expert at the American Cancer Society.
Experts say more research is needed through a study that, instead of relying on women’s memories about what they ate, asks them to keep food diaries and then follows them for years afterward to see which ones develop cancer. Finding dietary links to breast cancer is important because diet is one of the few risk factors a woman can easily modify.
“This study alone isn’t enough for people to make changes in their diet, but it’s a cautionary sign,” Willett said. The Institute of Medicine recommends that carbohydrates constitute 45 percent to 65 percent of calories, and that no more than 20 percent should come from added sugars, said Schlicker, who served on the panel that drafted the advice. New dietary guidelines are due to be released next year.

“Men ‘in denial’ over weight gain” (BBC/Cancer Research UK)

Around a quarter of British men are “in denial” about their waist measurement, a Cancer Research UK survey suggests. Official statistics show that 65% of adult men are overweight or obese, but the survey of over 2,000 men found only 40% thought they were in these groups. Most of the men questioned were unaware being overweight or obese, or inactive, increases the risk of cancer. Experts urged overweight men to become more active and eat a balanced diet rich in fruit and vegetables.

The survey was released to launch Cancer Research UK’s Man Alive Campaign. Around 65% of those questioned had no idea that being overweight or obese increased their chance of developing cancer, with 75% not aware that being physically inactive also increased their risk. The survey also found just 22% of those questioned eat five portions of fruit and vegetables per day, and two-thirds fail to meet the recommended target of 30 minutes of moderate exercise five times a week. Cancer Research UK experts said men were not heeding health warnings to maintain a healthy body weight.

Women ‘aware’

They warned obesity could be responsible for as many as 40,005 cases of cancer in UK men every year. Recently published research suggested obesity increases the risk of bowel cancer by 60%. Being obese also doubles the risk of being diagnosed with kidney, oesophageal and stomach cancer, as well as being a risk factor for bladder cancer. Good diet and regular exercise are two factors that can help in reducing the risk of developing cancer, they said. Professor Jane Wardle, the director of Cancer Research UK’s Health Behaviour Unit, said: “In the space of 10 years, the rate of obesity for British men has increased two thirds.

“Women are overweight too but our research shows that more of them know they have a problem and that’s the first step in putting it right.” She added: “Men need to be made aware of the problem, know how to fix the problem and be given the support to succeed. “Only then will they reduce their risk of cancer.” ‘Wake up call’ Dr Lesley Walker, director of information at Cancer Research UK, said: “It’s vital that men understand how they can reduce their risk of cancer.”The best present that anyone can give themselves is to stop smoking; it is by far the most important step in reducing cancer risk.” But she added: “In men who don’t smoke, obesity is one of the biggest known causes of preventable cancer.

“With rates of obesity for UK men growing faster than anywhere else in Europe, we are sounding a wake up call to all men and their partners to become more active, eat healthier diets and make sensible lifestyle choices. “To lose those spare tyres, be more active and eat a balanced diet that is rich in fruit and veg and low in sugar and fat.”

 

Cannabis Extract Shrinks Brain Tumors

Cannabis extracts may shrink brain tumours and other cancers by blocking the growth of the blood vessels which feed them, suggests a new study. An active component of the street drug has previously been shown to improve brain tumours in rats. But now Manuel Guzmán at Complutense University, Spain, and colleagues have demonstrated how the cannabis extracts block a key chemical needed for tumours to sprout blood vessels – a process called angiogenesis.

And for the first time, the team has shown the cannabinoids impede this chemical in people with the most aggressive form of brain cancer – glioblastoma multiforme. Cristina Blázquez at Complutense University, and one of the team, stresses the results are preliminary. “But it’s a good point to start and continue,” she told New Scientist. “The cannabinoid inhibits the angiogenesis response – if a tumour doesn’t do angiogenesis, it doesn’t grow,” she explains. “So if you can improve angiogenesis on one side and kill the tumour cells on the other side, you can try for a therapy for cancer.” “This research provides an important new lead compound for anti-cancer drugs targeting cancer’s blood supply,” says Richard Sullivan, head of clinical programmes, at Cancer Research UK.

Fat molecule

The team tested the effects of delta-9-tetrahydrocannabinol in 30 mice. They found the marijuana extract inhibited the expression of several genes related to the production of a chemical called vascular endothelial growth factor (VEGF). VEGF is critical for angiogenesis, which allows tumours to grow a network of blood vessels to supply their growth. The cannabinoid significantly lowered the activity of VEGF in the mice and two human brain cancer patients, the study showed. The drug did this by increasing the activity of a fat molecule called ceramide, suggests the study, as adding a ceramide inhibitor stifled the ability of the cannabinoid to block VEGF.

Small and pallid

“We saw that the tumours [in mice] were smaller and a bit pallid,” adds Blázquez. The paleness of the cancer reflected its lack of blood supply as a result of the treatment. In the human patients, she says: “It seems that it works, but it’s very early.” Sullivan points out: “Although this work is at an early stage of development other research has already demonstrated that VEGF is an important drug target for a range of cancers.” He emphasises the need for further work on cannabinoid combinations. “Cannabinoids would need to generate very strong data in the future as there are already a number of VEGF inhibitors in clinical development,” he says. The two patients in the ongoing study are among 14 in a clinical trial of the drug. The patients are given one cycle of treatment, lasting a few days, and their survival and general health are being studied.

 

Viral Cancer Research – 1959

Surgeon Fired by Son’s Death Finds Virus May Cause Cancer

ATLANTIC CITY, Sept. 28 – When Dr. James T. Grace yr. watched his two-year old son die of leukemia in 1955, the medical part of his mind thought of one thing: infection. Healthy, playful one day, the child’s temperature shot up to 105 degrees the next; his glands swelled; he became toxic and in a few months he was dead.

So Dr. Grace gave up his private practice of surgery in Nashville, Tenn., and set out to discover if leukemia, the blood cancer that killed James T. Grace 3d, was caused by a germ — a virus perhaps. He moved to the Roswell Park Cancer Research Institute in Buffalo, N.Y.    Today Dr. Grace told the American College of Surgeons’ annual meeting here that he has evidence that not only leukemia but other human cancers as well may be caused by an infectious agent.

By grinding up malignant cancers cut from leukemia and other cancer victims, Dr. Grace and his Buffalo colleagues have infected mice with the human disease. They are first to do it on a large scale. Their evidence suggests but does not prove that a virus may be the culprit in the human ailment in the same way that the viruses caused the disease in animals. It is an infection; however, it is a strange kind of infection: you have to get it before or soon after birth.

So important do scientists consider the new finding that $500,000 has been obtained to narrow the search for the cancer-causing agent. Twenty-five scientists and technicians now work with thousands of mice, hamsters and monkeys. And the virus work now dominates a new building at the Buffalo institute.

Telling the story to his fellow surgeons, Dr. Grace said that many cancers in mice, rabbits and other species can be brought on by viruses. These ultramicroscopic bundles of chemicals, which in some forms are responsible for polio, colds and a host of other diseases, usually can be recovered from the growing animal cancer. Injected into another animal, the viruses caused the malignant disease there.

But there is only one case in which a “virus-like” substance recovered from human leukemia had produced a leukemia in mice. Whether that virus actually came from the human tissue or was a contaminant is still a matter of controversy. About three years ago, Dr. Grace discovered a chemical difference bewteen normal human tissue and cancer tissue. In trying to run down the difference, Dr. Grace’s mind again turned to infection with viruses as a possibility.

Why not try infecting mice with human cancers? Other scientists were able to do this by blasting the mice with X-rays or chemicals and then transplanting a lump of cancer flesh. There was only the one doubtful case on record of a virus recovery from a human being. Dr. Grace then recalled the experiments of Dr. Ludwig Gross of the Veterans Administration Hospital in the Bronx, N.Y. Dr. Gross could transfer a virus cancer from mouse to mouse by injecting cancer extracts — not lumps of tissue — into the new-born animal, a creature literally as big as a peanut.

Dr. Grace decided to try it with extracts of human cancer. First he ground up human cancer tissue removed at surgery. Next he extracted the solid matter and all cells. To make sure there was no solid matter left, he filtered the extract. Only a virus or a non-living chemical could slip through the filter’s fine pores. He injected about 1,000 new-born mice and waited for cancers.

To make sure he wasn’t deluding himself, Dr. Grace kept a controlled group of the same family of mice. He also tried to “grow” a human cancer virus in test tubes and injected that stuff too. But neither group developed the malignant disease. The mice injected with the filtered extracts of living cancer did develop cancer, particularly pregnant mice. Although Dr. Grace took his tissue from twenty different human cancers, most of the diseased mice developed malignant breast growths.

What is Dr. Grace looking for now? He and his colleagues, Dr. J.A. DiPaolo, Dr. E.A. Mirand, both Ph.D.’s, and J.R. Haas want to identify the virus or viruses precisely. They want to grow the virus in test tubes. But there is a danger in that procedure. A virulent form of the virus could in principle infect the workers. ”We’ve turned our laboratory into Fort Know,” Dr. Grace said at an interview. “You can’t get in and out without taking a shower. We’ve already increased the deadliness of the virus so that it produces cancer in mice ib seven days rather than forty.” This was done by transferring it from animal to animal.

And eventually Dr. Grace looks toward making a preventive vaccine against disease. This can be done either with a killed virus, with the Salk technique, or with a weakened cancer virus. It’s a long way to go Dr. Grace admits, but he never again wants to watch a child die of leukemia.

 

Marijuana May Stall Brain Tumor Growth

Researchers say the cannabinoids found in marijuana may aid in brain tumor treatment by targeting the genes needed for the tumors to sprout blood vessels and grow. Their study showed that cannabinoids inhibited genes needed for the production of vascular growth factor (VEGF) in laboratory mice with glioma brain tumors and two patients with late-stage glioblastoma multiforme, a form of brain cancer.

VEGF is a protein that stimulates blood vessels to grow. Tumors need an abundant blood supply because they generally grow rapidly. So when VEGF is blocked, tumors starve from lack of blood supply and nutrients. Blocking of VEGF constitutes one of the most promising tumor-fighting approaches currently available, says researcher Manuel Guzman, professor of biochemistry and molecular biology, at the Complutense University in Madrid, Spain, in a news release.

Guzman says the findings suggest VEGF may be a new target for cannabinoid-based treatments. Previous studies have shown that cannabinoids could inhibit the growth of tumor-associated blood vessels in mice, but until now little was known about how they worked. The results of the study appear in the Aug. 15 issue of the journal Cancer Research. Cannabinoids May Help Starve Tumors

In the study, researchers looked at the effects of cannabinoid treatment on gliobastoma multiforme, a form of brain cancer that affects about 7,000 Americans each year. It’s considered one of the deadliest forms of cancer and usually results in death within one to two years after diagnosis. Treatment typically involves surgery, followed by radiation and/or chemotherapy. But despite these efforts to destroy the tumor, this type of brain tumor often survives and starts growing again, which is why researchers are looking for novel ways to attack it.

In order to grow, all tumors require a network of blood vessels to feed them, and they create this network through a process known as angiogenesis. VEGF is critical to this process. In the first part of the study, researchers induced brain cancer in mice and then treated them with cannabinoids. They then analyzed the genes associated with the growth of blood vessels in the tumor and found that cannabinoids inhibited several of the genes related to VEGF. In the second part of the study, researchers injected cannabinoids into tumor samples taken from two human glioblastoma patients.

“In both patients, VEGF levels in tumor extracts were lower after cannabinoid inoculation,” says Guzman. Researchers say more study is needed but the results suggest that cannabinoid-based therapies may offer a new alternative for treatment of these otherwise untreatable brain tumors.

 

USA Today: “Plant foods to the rescue”

Scientists who study nutrition paint a very different picture.

A growing body of research shows that, once inside the body, fruits and vegetables spring into the role of superheroes, fighting cancer and other diseases in at least eight simultaneous ways. And, like the Superfriends, they seem to work better as a team. Some phytochemicals, or plant chemicals, knock out carcinogens and fight inflammation. Some regulate how quickly cells reproduce and spur old, damaged cells to self-destruct. Other plant chemicals perform “routine maintenance” on DNA, says Jeff Prince, vice president for education at the Washington-based American Institute for Cancer Research.

Doctors caution that recent research indicates that fruits and vegetables may not provide as much protection against cancer as once believed. In the past five years, studies have shown that weight control may be more crucial, says Walt Willett, chairman of the nutrition department at the Harvard School of Public Health.

Yet most experts agree that the body needs a variety of these phytochemicals – there are more than 25,000 of them – to stay in top form. That’s why so many nutritionists no longer stress individual “power foods,” Prince says, but instead promote a “plant-based” diet of fruits, vegetables, whole grains, beans and nuts. Preliminary research indicates these foods bring out the best in each other and magnify their protective effects.

At the cancer institute’s annual scientific conference in July, researchers from the University of Illinois-Urbana described their research feeding tomatoes and broccoli to lab rats that had prostate cancer. The tumors of rats that were fed both vegetables shrank far more than those of animals who ate either food alone. Researchers stressed, though, that people do not necessarily react the same way as animals and that many larger studies need to be done to confirm these results.

“The take-home message is not that experts recommend tomatoes and broccoli,” Prince said at the conference. “We’re not going to find a single source that fights disease. What’s important is the interaction of thousands of plant chemicals.” Humans evolved to depend on a rich diet of 800 plant foods, says David Heber, director of the University of California-Los Angeles Center for Human Nutrition. Today, he says, most people eat three, and those are often french fries, ketchup and iceberg lettuce.

Yet some potentially potent plant foods, experts say, are exotic varieties that Americans rarely sample: herbs such as ginseng; spices such as turmeric, used in Indian cooking; and Reishi and Maitake mushrooms from Japan. Heber suggests that people select their five to nine recommended daily servings of fruits and vegetables from seven color groups, such as purple grapes or yellow squash, whose colors are produced by disease-fighting chemicals called carotenoids.

Scientists have identified only a handful of the thousands of potentially beneficial plant chemicals, says Daniel Nixon, author of The Prostate Health Program and president of the Institute for Cancer Prevention in New York. People who would rather pop dietary supplements instead of eating the real thing may miss out on proven health promoters such as fiber, as well as compounds that scientists have yet to discover, Nixon says. Last week, the American Heart Association published an advisory finding that antioxidant supplements do not prevent heart disease. In some studies, supplements with beta carotene – the chemical that colors carrots orange – increased the risk of cancer.

Plants vs. disease

Plant foods, however, may help prevent a number of diseases, says Rachel Brandeis of the American Dietetic Association. Antioxidants found in vegetables neutralize dangerous molecules called “free radicals,” which are produced by smoking and radiation, as well as everyday activities of the body. Left to themselves, free radicals attack healthy cells and may lead to plaques in the arteries and even Alzheimer’s. They also can damage DNA in ways that lead to cancer. As plants evolved, they developed antioxidants to fight free radicals, Heber says. Humans grew to depend on fruits, vegetables and nuts to provide these vital defenses. That may explain why, without a rich plant diet, people are more vulnerable to disease. Diets rich in plant compounds, on the other hand, may prevent a variety of ailments.

At a meeting of the Alzheimer’s Association last month, for example, researchers presented the results of a six-year study of 3,000 senior citizens. In the study, people who consumed lots of vitamin C and carotenoids, both through food and supplements, scored higher on reasoning tests. Carotenoids are found in squash, strawberries and other fruits. According to another study presented at the meeting, vegetables such as spinach and broccoli – which contain vitamin C and carotenoids, as well as the vitamin folic acid – were found to slow cognitive decline.

Other things that appear to lower the risk of Alzheimer’s include vitamin E, found in wheat germ, and fatty fish, such as salmon and mackerel, which are rich in omega-3 fatty acids, according to the Alzheimer’s Association. Scientists say they still have many questions about antioxidants: Can they fight cancer at any stage of the disease or at any age? Or do people benefit only if they consume these foods from infancy? Under which circumstances might antioxidants promote disease, rather than healing?

Scientists have identified at least a handful of the ways that plant foods appear to fight disease, says Cheryl Rock, a professor of nutrition at the University of California-San Diego Cancer Center. * By mopping up free radicals, antioxidants such as the beta carotene in sweet potatoes or the vitamin E in almonds prevent cell damage. Another class of chemicals called flavonoids have been shown to activate the body’s natural DNA repair system.

* Fruits and vegetables often are high in potassium, which can help control blood pressure.

* Antioxidants may interrupt a process leading to inflammation, which appears to play a role in cardiovascular disease and cancer. Vitamin B6, found in bananas, and folic acid, found in broccoli and leafy greens, both lower levels of homocysteine, which has been linked to hardening of the arteries, heart attacks, strokes and dementia.

* Chemicals such as beta carotene also help regulate the natural cycle of cell birth and death, telling cells when to divide, differentiate into new types or recycle themselves. Keeping this process under tight control can prevent cancer, Rock says.

* Phytochemicals in foods such as Brussels sprouts, red cabbage and kale may help prevent cancer by activating enzymes that break down carcinogens.

Antioxidants vs. angiogenesis

* Emerging research suggests that antioxidants may shut down a process called angiogenesis, by which tumors recruit blood supplies that help them grow and spread, says William Li, president of the Angiogenesis Foundation. Scientists are investigating links between angiogenesis and compounds found in foods such as licorice, blueberries and garlic, Li says.

Researchers who studied tumors in mice were able to cut back the number of new blood vessels by 70% simply by replacing their water with green tea, Li says. Scientists have not proved this link in humans.

* Plant foods such as whole-grain cereals and oats are loaded with fiber. In a study of 40,000 male health professionals, high-fiber diets reduced the risk of coronary heart disease by 40%. Diets filled with cereal fiber also may help prevent diabetes and a painful intestinal inflammation called diverticular disease. “Mother Nature is cleverer than all of us and has laced many of our favorite foods with things that can be helpful,” Li says. “Ancient cultures have long recognized that your diet can be healing, and
scientists are only now beginning to understand why.” Digest the benefits of this basket of foods

Many nutritionists today stress the importance of healthy dietary patterns – ones filled with vegetables, fruits, whole grains, beans, nuts and lean proteins – combined with regular exercise and weight control. Though no one food is a “magic bullet,” some experts encourage people to include foods such as these in their diets.

Digest the benefits of this basket of foods

Many nutritionists today stress the importance of healthy dietary patterns ones filled with vegetables, fruits, whole grains, beans, nuts and lean proteins – combined with regular exercise and weight control. Though no one food is a “magic bullet,” some experts encourage people to include foods such as these in their diets. Tomatoes The carotenoid lycopene. Eating several servings a week may reduce the risk of prostate cancer up to 35% and also may reduce the risk of heart attack and stroke. To get the most lycopene, cook tomatoes with a little “healthful” fat, such as olive oil.

Whole-grain breads and cereals Fiber and antioxidants. May lower the risk of heart disease by 40%. May also help prevent diabetes. Read labels to make sure that the first ingredient in the bread says whole wheat, not just wheat or “stone-ground wheat.” Salmon, mackeral, sardines Omega-3 fatty acids. Reduces risk of heart disease, diabetes and possibly Alzheimer’s and cancer. Reduces inflammation, which may help prevent or relieve symptoms of arthritis. Contains vitamin D, which builds strong bones and may protect against colon cancer. Cooked, to kill microorganisms and parasites. Broiled, to eliminate contaminants found in freshwater fish. For canned fish, serve with the soft, mashed, calcium-rich bones.

Spinach and other leafy greens Folic acid. This may reduce risk of birth defects, heart attack, Alzheimer’s, depression and inflammation. Folic acid also reduces the risk of fractures. Potassium lowers blood pressure and the danger of strokes. The carotenoids lutein and zeaxanthin may help fight age-related eye disease. Antioxidants called flavones may reduce breast cancer risk.  Fresh or lightly steamed to preserve vitamin C; with nuts, olive oil or avocados, whose fat helps to increase absorption of antioxidants.

Blueberries or other berries Antioxidants such as vitamin C. These may reduce risk of heart disease, cancer, mental decline and other diseases of aging. May help prevent urinary-tract infections by inhibiting bacteria.  Fresh, raw or lightly cooked. Wash them just before serving to avoid mold and bruising. Canning blueberries removes half of the vitamin C. Sweet potatoes Carotenoids, which may help reduce the risk of Alzheimer’s. Beta carotene also may lower the risk of cancers of the larynx, esophagus and lungs. Baked or boiled.

 

NEW VERSION OF TEST FOR CANCER-CAUSING AGENTS NEEDS NO ANIMALS

A new version of a popular test for cancer-causing agents is cheaper, more sensitive and, best of all, animal-free, thanks to a U of G researcher. Prof. David Josephy, Chemistry and Biochemistry, has developed a way of testing substances for cancer-causing potential without using animal tissue. Instead, his version of the Ames test involves gene splicing.

“Nobody has figured a way around using animals until now,” says Josephy. “We hope that no more animals will have to die for the sake of the Ames test.” Two decades ago, the Ames test (named after inventor Bruce Ames, a bacterial geneticist from the University of California at Berkeley) was heralded as a breakthrough in cancer research. Ames’s goal was to eliminate the use of animals in tests for cancer-causing or “mutagenic” agents.

In his efforts to put an end to animal use, Ames came up with a way to use animal tissue for his tests, rather than the whole animal. In animals, cancer-causing agents are inactive until they’re chemically changed or “metabolized” by certain enzymes. When they’re changed, they become dangerous because they’re converted into different forms of chemicals.

Ames chose rodent liver extracts for his test because the liver contains more metabolic enzymes than other organs do. In a test tube, he combined liver cells and bacteria. He used bacteria because they’re so small that billions of cells can be affected by the mutagen in one test, making results easier to observe. When a potential cancer-causing agent is introduced into the test tube, it’s metabolized by the enzymes in the liver and causes DNA damage or mutations to the bacterial cells. DNA damage mutates cells, which results in cancer in animals.

The test has enabled researchers to identify carcinogens such as the charring on burnt food and a chemical used to fireproof children’s pyjamas, which was banned after the discovery was made. The Ames test used only a portion of a rodent’s liver. That meant it reduced the use of animals needed to detect suspected mutagens because one liver provided enough material for hundreds of tests. With the Ames test, mutagen-detection laboratories need to use only a few dozen rodent livers each year instead of the thousands of animals that lifetime feeding tests would require.

Now Josephy has taken that a step further. He has completely eliminated the need for animals to be involved. In the last few years, researchers have identified the gene — called P4501A2 — that makes the enzyme needed to metabolize carcinogens so they become mutagenic. Different enzymes metabolize different carcinogens; the enzyme P4501A2 metabolizes one class of compounds called aromatic amines, the carcinogens in charred material.

Josephy spliced the P4501A2 gene into the bacterial cell responsible for producing the metabolizing enzyme that identifies it as a mutagen. By splicing the gene into the bacteria, he’s made it possible for the bacteria to produce the required enzyme, so that no rat liver is needed. As a result, when potential mutagenic chemicals are introduced, the bacteria are a complete mutagen-detecting package  in themselves.

Josephy has installed a clone of the human P4501A2 gene into the bacteria to make the test even more representative of human metabolism. The cloned human genes come from Peter Guengerich, a collaborator at the Vanderbilt University School of Medicine in Nashville. “It means we can do a much more sophisticated mutagen analysis than we could in the past,” says Josephy. “We’re fulfilling Ames’s goal.” This work is sponsored by the National Cancer Institute of Canada and the Natural Sciences and Engineering Research Council.

 

US-CA, An Associate Scientist in Cell Biology, Cancer Research

COMPANY
Well-equipped U.S. research headquarters of international drug discovery company. Attractive campus. Excellent resources. High caliber of science. Company is committed to cutting edge research. Provides cutting-edge tools and support. Highly collaborative environment.

DESCRIPTION
Cell biology associate scientist for a cancer research group heavily focused on breast cancer. Apply 3 to 5 years of relevant experience ideally acquired within an industrial biotech environment.

RESPONSIBILITIES
Within a cell biology department, support cancer research genomics program focused on breast cancer. Apply knowledge in cell biology, cell based assays, cell-cell and cell-matrix signaling mechanisms, and antibody experience. Develop, optimize and perform cell-based assays to evaluate novel-gene therapeutic candidates. Validate novel protein drug targets utilizing strategies such as neutralizing antibodies and anti-sense oligonucleotide-based gene knock-outs. Another validation method used will be transfections of wild-type and dominant negative protein.

LOCATION
San Francisco Bay Area.
QUALIFICATIONS
BS or MS in cell biology with 3 to 5 years of pertinent experience, ideally within an industrial biotech setting. Broad knowledge of cell biology. Cell based assay experience (ex: proliferation, apoptosis, migrations and/or invasion assays). Experience working with cancer cell lines. The ability to manipulate a cell is important. Two crucial areas of technical knowledge are: 1.) Mammalian cell transfection and 2.) Delivering antisense oligonucleotides. Ideally we are seeking experience in the culture and transfection of primary and established human cell lines. Strong interpersonal and problem solving skills also important..

DESIRED (Not Mandatory)
Possible growth factor experience. Extracellular matrix interaction. Familiarity with: DNA expression vectors. Antisense olignucleotides. Immuno-cytochemistry and antibody characterization. Molecular biology techniques: such as cDNA cloning, DNA and RNA isolation. Northern and Western blot analysis.

COMPENSATION
Competitive salary and benefits.

 

Postage Stamp to Raise Money for Cancer Research

LOS ANGELES- the Postal Service unveiled the design of the Breast Cancer Research “Semipostal” Stamp, here, at the Revlon Run and Walk for Women on May 9th. A nationwide issuance of this  self-adhesive stamp begins in early August.

As a 40 cent “semipostal,” the Breast Cancer Research stamp will be deemed valid for postage at the prevailing First Class Rate, currently 32 cents, with the extra 8 cents going to fund medical research at the National Institutes of Health (70 percent) and Department of Defense (30 percent).

The background of the vertically formatted stamp design features blue,yellow, orange, and green washes of watercolor.  Along the top are the words, “breast cancer” in capital letters.  A black ink drawing of a female figure is the main element, while the phrases “fund the fight” and “find a cure” appear in capital letters flowing left to right into a clockwise, circular pattern.

The stamp was designed by Ethel Kessler, a breast cancer survivor, of Bethesda, MD, and illustrated by Whitney Sherman of Baltimore, MD. This is the first time in history that the U.S. Postal Service has issued a “semipostal” stamp.  It took an act of Congress after “grass roots” campaigning by several groups led by Dr. Ernie Bodai of Sacramento, CA, to get this unique postage stamp issued.

Among the thousands at the unveiling ceremony, was Mercy Davidchik of Yuba City, CA, who was one of the most active volunteer workers in raising public support and promoting legislation to issue the Breast Cancer Research Stamp.   It is hoped that through purchase of these stamps, millions of dollars will be raised for breast cancer research, which  is considered the most commonly diagnosed cancer among all women in the U.S.